Selected Publications

Seals RM, Hansen J, Gredal O, Weisskopf MG. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. Am J Epidemiol. 2013 Oct 15;178(8):1265-71.

Weisskopf MG, Moisan F, Tzourio C, Rathouz PJ, Elbaz A. Pesticide exposure and depression among agricultural workers in France. Am. J. Epidemiol. 2013 Oct 1;178(7):1051-8.

Roberts AL, Kristen L, Hart JE, Laden F, Just AC, Bobb JF, Koenen KC, Ascherio A, Weisskopf MG. Perinatal exposure to air pollution is associated with increased risk of autism spectrum disorder. Environ. Health Perspect. 2013 Aug;121(8):978-84.

Roberts AL, Lyall K, Rich-Edwards JW, Ascherio A, Weisskopf MG. Association of maternal exposure to childhood abuse with elevated risk of autism in offspring. JAMA Psychiatry 70(5):508-515, 2013.

Grashow R, Miller MW, McKinney A, NieLH, SparrowD, Hu H, Weisskopf MG. Lead exposure and fear-potentiated startle in the VA Normative Aging Study: A pilot study of a novel physiological approach to investigating neurotoxicant effects. Neurotoxicol. Teratol., 38C:21-28, 2013.

Eum KD, Korrick SA, Weuve J, Okereke O, Kubzansky LD, Hu H, Weisskopf MG. Relation of chronic low-level lead exposure to depressive and phobic anxiety symptoms in women. Environ Health Perspect. 2012 Jun;120(6):817-23.

LaohaudomchokW, Lin X, Herrick RF, Fang SC, Cavallari JM, Christiani DC, Weisskopf MG. Toenail, blood and urine as biomarkers of manganese exposure. J. Occup. Environ. Med. 53(5):506-10, 2011.

Nie LH, Sanchez S, Newton K, Grodzins L, Cleveland R, Weisskopf MG. In vivo quantification of lead in bone with a portable XRF system – methodology and feasibility. Physics in Medicine and Biology 56(3):N39-51, 2011.

Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, Hersh B, Schwartz J, Wright RO, Hu H. Association of cumulative lead exposure with Parkinson’s Disease. Environ Health Perspect. 118(11): 1609–1613, 2010.

Bouchard M, Bellinger DC, Wright RO, Weisskopf MG. Attention deficit/hyperactivity disorder and urinary organophosphate metabolites in U.S. children 8 to 15 years. Pediatrics 125(6):e1270-77, 2010.

Weisskopf MG, Knekt P, O’Reilly EJ, Lyytinen J, Reunanen A, Laden F, Altshul L, Ascherio A. Prospective study of serum organochlorine pesticides and Parkinson disease risk. Neurology 74(13):1055-61, 2010.

Bouchard M, Bellinger DC, Weuve J, Mathews-Bellinger J, Gilman SE, Wright RO, Schwartz J, Weisskopf MG. Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in U.S. young adults. Arch. Gen. Psychiatry 66(12):1313-19, 2009.

Dikmen SS, Corrigan JD, Levin HS, Machamer J, Stiers W, Weisskopf MG. Cognitive outcome following traumatic injury. J. Head Trauma Rehabil. 24(6):430-438, 2009.

Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, Schwartz J, Hu H. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the VA Normative Aging Study. Circulation 120(12):1056-64, 2009.

Weisskopf MG, Morozova N, O’Reilly E, McCullough ML, Calle EE, Thun MJ, Ascherio A. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 80(5):558-61, 2009.

Weisskopf MG, Ascherio A. Cigarettes and Amyotrophic Lateral Sclerosis: Only smoke or also fire? Ann. Neurol. 65(4):361-362, 2009.

Weisskopf MG, O’Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson’s disease. Am. J. Epidemiol. 166(5):561-567, 2007.

Weisskopf MG, Hu H, Sparrow D, Lenkinski RE, WrightRO. Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus. Environ. Health. Perspect. 115(4):519-523, 2007.

Weisskopf MG, Myers GJ. Cumulative effect of lead on cognition: Is bone more revealing than blood? Neurology 67(9):1536-7, 2006.

Weisskopf MG, O’Reilly EJ, McCullough, ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of military service and mortality from Amyotrophic Llateral Sclerosis. Neurology 64(1):32-7, 2005.

Weisskopf MG, Wright RO, Schwartz J, Spiro III A, Sparrow D, Aro A, Hu H. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am. J. Epidemiol. 160(12):1184-93, 2004.

Weisskopf MG, Hu H, Mulkern RV, White R, Aro A, Oliveira S, Wright RO. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ. Health. Perspect. 112(5):620-625, 2004.

Weisskopf MG , Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson’s disease. Mov. Disord. 18(6):646-51, 2003 .

Weisskopf MG , Hanrahan LP, Anderson HA, for the Great Lakes Consortium. Decreased sex ratio following maternal exposure to polychlorinated biphenyls from contaminated Great Lakes sport-caught fish: a retrospective cohort study. Environ. Health. 2:2, 2003.

Centers for Disease Control and Prevention; Public health dispatch: Potential risk of lead exposure in dental offices. Morb Mort. Wkly Rep. 50(40):873-874, 2001.

Weisskopf MG, Bauer EP, LeDoux JE. L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala; J. Neurosci. 19:10512-10519, 1999.

Weisskopf MG, Nicoll RA. Presynaptic changes during mossy fibre LTP revealed by NMDA receptor-mediated synaptic responses. Nature 376:256-259, 1995.

Weisskopf MG, Castillo PE, Zalutsky RA, Nicoll RA. Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 265:1878-1882, 1994.

Weisskopf MG, Zalutsky RA, Nicoll RA. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362:423-427, 1993.